GSA Capital Partners LLP Purchases 24,555 Shares of Liquidia Corporation $LQDA

GSA Capital Partners LLP raised its position in shares of Liquidia Corporation (NASDAQ:LQDA) by 63.6% in the fourth quarter, HoldingsChannel reports. The firm owned 63,176 shares of the company’s stock after buying an additional 24,555 shares during the quarter. GSA Capital Partners LLP’s holdings in Liquidia were worth $2,179,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also made changes to their positions in LQDA. Farallon Capital Management LLC grew its stake in shares of Liquidia by 102.1% during the 3rd quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company’s stock valued at $194,783,000 after purchasing an additional 4,326,876 shares during the period. TCG Crossover Management LLC bought a new stake in shares of Liquidia during the 3rd quarter valued at about $38,887,000. Caprock Group LLC bought a new stake in shares of Liquidia during the 3rd quarter valued at about $37,114,000. Voloridge Investment Management LLC bought a new stake in shares of Liquidia during the 3rd quarter valued at about $12,571,000. Finally, Apis Capital Advisors LLC bought a new stake in shares of Liquidia during the 3rd quarter valued at about $9,569,000. 64.54% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. Jefferies Financial Group restated a “buy” rating and set a $60.00 price target on shares of Liquidia in a research note on Monday, May 11th. Lifesci Capital upgraded Liquidia to a “strong-buy” rating in a research note on Thursday, March 5th. BTIG Research boosted their price target on Liquidia from $50.00 to $59.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Liquidia in a research report on Tuesday, April 21st. Finally, Zacks Research raised Liquidia from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 5th. Three research analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Liquidia has a consensus rating of “Moderate Buy” and an average target price of $49.33.

Insider Buying and Selling

In related news, CFO Michael Kaseta sold 139,390 shares of the business’s stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $40.14, for a total value of $5,595,114.60. Following the transaction, the chief financial officer directly owned 353,356 shares of the company’s stock, valued at approximately $14,183,709.84. The trade was a 28.29% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Roger Jeffs sold 32,744 shares of the business’s stock in a transaction that occurred on Monday, April 13th. The stock was sold at an average price of $38.37, for a total value of $1,256,387.28. Following the completion of the transaction, the chief executive officer directly owned 1,137,599 shares in the company, valued at approximately $43,649,673.63. This represents a 2.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 1,022,713 shares of company stock valued at $44,689,753. Corporate insiders own 25.60% of the company’s stock.

Liquidia Stock Up 0.1%

NASDAQ LQDA opened at $56.97 on Tuesday. The stock’s 50 day moving average is $40.15 and its 200 day moving average is $36.27. The company has a current ratio of 2.22, a quick ratio of 2.03 and a debt-to-equity ratio of 1.18. Liquidia Corporation has a 12 month low of $11.85 and a 12 month high of $59.75. The stock has a market cap of $5.07 billion, a PE ratio of 406.96 and a beta of 0.41.

Liquidia (NASDAQ:LQDA) last posted its quarterly earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The company had revenue of $132.87 million for the quarter, compared to analysts’ expectations of $119.44 million. Liquidia’s quarterly revenue was up 4187.1% on a year-over-year basis. Research analysts predict that Liquidia Corporation will post 2.97 EPS for the current fiscal year.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).